<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncotarget</journal-id><journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type="epub">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28903438</article-id><article-id pub-id-type="pmc">5589677</article-id><article-id pub-id-type="publisher-id">14821</article-id><article-id pub-id-type="doi">10.18632/oncotarget.14821</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research Paper</subject></subj-group></article-categories><title-group><article-title>A novel prognostic index for oral squamous cell carcinoma patients with surgically treated</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Chen</surname><given-names>Fa</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Cao</surname><given-names>Yujie</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Jiangfeng</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Lingjun</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Lisong</given-names></name><xref ref-type="aff" rid="A4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Fengqiong</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Fangping</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Junfeng</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="A4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cai</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Baochang</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib></contrib-group><aff id="A1"><sup>1</sup> Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fujian, China</aff><aff id="A2"><sup>2</sup> Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fujian, China</aff><aff id="A3"><sup>3</sup> Department of Stomatology, The First Affiliated Hospital of Fujian Medical University, Fujian, China</aff><aff id="A4"><sup>4</sup> Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Fujian Medical University, Fujian, China</aff><author-notes><corresp id="cor1"><bold><italic>Correspondence to:</italic></bold><italic>Baochang He,</italic><email>prof_hbc@163.com</email></corresp></author-notes><pub-date pub-type="collection"><day>15</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>26</day><month>1</month><year>2017</year></pub-date><volume>8</volume><issue>33</issue><fpage>55525</fpage><lpage>55533</lpage><history><date date-type="received"><day>30</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>11</day><month>1</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2017 Chen et al.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License 3.0</ext-link> (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>This study aims to develop an applicable prognostic index with conventional factors for predicting outcome of patients with oral squamous cell carcinoma (OSCC). We performed a prospective study in a large cohort of 892 OSCC patients in Fujian, China. All patients were randomly divided into a discovery group and validation group. A prognostic index was developed based on &#x003b2; value of each significant variable obtained from the multivariate Cox regression model. The results from discovery and validation set demonstrated thatthe model-4(included clinical stage, tumor differentiation, ill-fitting denture, oral hygiene and cigarette smoking) was the optimal model. The optimal cutoff points of prognostic index (1.88 and 2.80) were determined by X-tile program which categorized all subjects into low, middle and high risk subsets. Patients in high risk group were at the greatest risk of death compared with those in low risk group (HR: 6.02; 95%CI: 4.33-8.38). Moreover, there was a significant tendency of the worse overall survival with the higher prognostic index (<italic>P</italic>trend &#x0003c;0.001). The discriminatory capacity of prognostic index was 0.661(95%CI: 0.621-0.701). This study developed and validated a prognostic index that is an economical and useful tool for predicting the clinical outcomes of OSCC patients in Southeast China. Future randomized trials with larger cohort are required to confirm our results.</p></abstract><kwd-group><kwd>oral squamous cell carcinoma</kwd><kwd>prognostic prediction model</kwd><kwd>prognostic index</kwd><kwd>overall survival</kwd><kwd>prospective study</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>INTRODUCTION</title><p>Oral squamous cell carcinomas (OSCC) is the predominant histological type in oral carcinomas and has a rising morbidity and mortality in many countries [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>]. Despite many advances in the diagnosis and treatment, long-term survival of OSCC only improved slightly over the past few decades, with 5-year survival rate still around 50% [<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>]. It is therefore essential to explore prognostic factors which would be better to predict OSCC patients&#x02019; prognosis.</p><p>Various parameters have been reported in previous studies for predicting the prognosis of OSCC, including clinicopathologic features (clinical stage, tumor differentiation, tumor size, and treatment types, etc.) [<xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref>], serum biomarkers (C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), etc.) [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>], human papillomavirus (HPV) infection [<xref rid="R10" ref-type="bibr">10</xref>] and patients&#x02019; lifestyle factors (smoking, alcohol drinking, oral hygiene, etc.) [<xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R12" ref-type="bibr">12</xref>]. However, few studies incorporate these prognostic parameters into a comprehensive index to evaluate the joint contribution to the prognosis of this disease.</p><p>Recently, prognostic prediction model with different independent prognostic factors has been proposed and became a promising method for reliable prediction of cancer prognosis. Tertipis et al. [<xref rid="R13" ref-type="bibr">13</xref>] utilised HLA class I, CD8+ TILs and clinical characteristics to predict the outcomes of tongue cancer patients. Rietbergen et al. [<xref rid="R14" ref-type="bibr">14</xref>] established a prognostic model included HPV infection, comorbidity and nodal stage for oropharyngeal squamous cell carcinoma. Almangush et al. [<xref rid="R15" ref-type="bibr">15</xref>] combined tumor budding and depth of invasion into a predictive model for tongue cancer. However, most of previous models contain costly biomarkers and not sufficiently validated with small sample size and short-term follow up.</p><p>Therefore, we performed a prospective study with large samples size and long-term follow-up to develop and validate a practical prognostic index (PI) using simple and easily available clinical parameters to predict the outcomes of OSCC patients in Southeast of China.</p></sec><sec id="s2"><title>RESULTS</title><p>The demographic characteristics of discovery group and validation group are listed in Table <xref ref-type="table" rid="T1">1</xref>. The 5-year overall survival (OS) rate for all OSCC patients was 67.6% (69.6% for discovery group and 66.0% for validation group). There was no significant difference in demographic characteristics between two groups (all <italic>P</italic> &#x0003e; 0.05).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Distribution of demographic characteristics between discovery and validation groups</title></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Variables</th><th align="center" valign="middle" rowspan="1" colspan="1">Discovery group(<italic>n</italic>= 446)</th><th align="center" valign="middle" rowspan="1" colspan="1">Validation group(<italic>n</italic>= 446)</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>P</italic><sup>b</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sex</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.158</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Female</td><td align="center" valign="middle" rowspan="1" colspan="1">163(36.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">143(32.06)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Male</td><td align="center" valign="middle" rowspan="1" colspan="1">283(63.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">303(67.94)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.177</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;60</td><td align="center" valign="middle" rowspan="1" colspan="1">242(54.26)</td><td align="center" valign="middle" rowspan="1" colspan="1">262(58.74)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;60</td><td align="center" valign="middle" rowspan="1" colspan="1">204(45.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">184(41.26)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI <sup>a</sup> (kg/m<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.385</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;18.5-23.9</td><td align="center" valign="middle" rowspan="1" colspan="1">280(62.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">264(59.19)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;18.5</td><td align="center" valign="middle" rowspan="1" colspan="1">71(15.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">86(19.28)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;24</td><td align="center" valign="middle" rowspan="1" colspan="1">95(21.30)</td><td align="center" valign="middle" rowspan="1" colspan="1">96(21.53)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Occupation</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.625</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Farmer</td><td align="center" valign="middle" rowspan="1" colspan="1">174(39.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">184(41.26)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Worker</td><td align="center" valign="middle" rowspan="1" colspan="1">96(21.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">100(22.42)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Staff and others</td><td align="center" valign="middle" rowspan="1" colspan="1">176(39.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">162(36.32)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Residence</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.310</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Urban</td><td align="center" valign="middle" rowspan="1" colspan="1">249(55.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">264(59.19)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Rural</td><td align="center" valign="middle" rowspan="1" colspan="1">197(44.17)</td><td align="center" valign="middle" rowspan="1" colspan="1">182(40.81)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Education level</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.579</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Primary and below</td><td align="center" valign="middle" rowspan="1" colspan="1">57(12.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">47(10.54)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Middle school</td><td align="center" valign="middle" rowspan="1" colspan="1">325(72.87)</td><td align="center" valign="middle" rowspan="1" colspan="1">334(74.89)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;College and above</td><td align="center" valign="middle" rowspan="1" colspan="1">64(14.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">65(14.57)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Family history of cancer</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.784</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="middle" rowspan="1" colspan="1">376(84.30)</td><td align="center" valign="middle" rowspan="1" colspan="1">373(83.63)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">70(15.70)</td><td align="center" valign="middle" rowspan="1" colspan="1">73(16.37)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><sup>a</sup> Body mass index (weight in kg/[height in m]<sup>2</sup>), BMI groups according to the classification criteria for Chinese adults; <sup>b</sup> Chi-square test</p></table-wrap-foot></table-wrap><p>Table <xref ref-type="table" rid="T2">2</xref> presents the HRs of potential prognosis factors for OSCC in discovery group. Advanced tumour stage was significantly associated with worse survival: the HRs were 4.57 (95% CI: 2.30-9.11) for stage IV, 4.36 (95% CI: 2.15-8.8) for stage III and 2.05 (95% CI: 1.01-4.15) stage II. Moreover, patients with moderate and poor histological differentiation had an increased risk for death (HR: 1.60 (95% CI 1.07-2.39) and 3.19 (95% CI: 1.98-5.15), respectively). Additionally, cigarette smoking, ill-fitting denture and poor oral hygiene also significantly elevated risk of death.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Univariate analysis of potential prognosis factors for OSCC patients in discovery group</title></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Variables</th><th align="center" valign="middle" rowspan="1" colspan="1">Number of Censored (%)</th><th align="center" valign="middle" rowspan="1" colspan="1">Number of death (%)</th><th align="center" valign="middle" rowspan="1" colspan="1">5-year OS (%)</th><th align="center" valign="middle" rowspan="1" colspan="1">HR(95 % CI)</th><th align="center" valign="middle" rowspan="1" colspan="1">Log-rank <italic>P</italic></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sex</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Female</td><td align="left" valign="middle" rowspan="1" colspan="1">122(38.01)</td><td align="left" valign="middle" rowspan="1" colspan="1">41(32.80)</td><td align="left" valign="middle" rowspan="1" colspan="1">67.91</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.344</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Male</td><td align="left" valign="middle" rowspan="1" colspan="1">199(61.99)</td><td align="left" valign="middle" rowspan="1" colspan="1">84(67.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">71.58</td><td align="left" valign="middle" rowspan="1" colspan="1">1.20(0.82-1.74)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (years)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;60</td><td align="left" valign="middle" rowspan="1" colspan="1">177(55.14)</td><td align="left" valign="middle" rowspan="1" colspan="1">65(52.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">72.80</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.295</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;60</td><td align="left" valign="middle" rowspan="1" colspan="1">144(44.86)</td><td align="left" valign="middle" rowspan="1" colspan="1">60(48.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">66.88</td><td align="left" valign="middle" rowspan="1" colspan="1">1.21(0.85-1.71)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;18.5-23.9</td><td align="left" valign="middle" rowspan="1" colspan="1">196(61.06)</td><td align="left" valign="middle" rowspan="1" colspan="1">84(67.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">69.25</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.077</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;18.5</td><td align="left" valign="middle" rowspan="1" colspan="1">46(14.33)</td><td align="left" valign="middle" rowspan="1" colspan="1">25(20.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">65.78</td><td align="left" valign="middle" rowspan="1" colspan="1">1.19(0.76-1.86)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;24</td><td align="left" valign="middle" rowspan="1" colspan="1">79(24.61)</td><td align="left" valign="middle" rowspan="1" colspan="1">16(12.80)</td><td align="left" valign="middle" rowspan="1" colspan="1">75.03</td><td align="left" valign="middle" rowspan="1" colspan="1">0.59(0.35-1.01)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Occupation</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Farmer</td><td align="left" valign="middle" rowspan="1" colspan="1">113(35.21)</td><td align="left" valign="middle" rowspan="1" colspan="1">61(48.80)</td><td align="left" valign="middle" rowspan="1" colspan="1">67.88</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.399</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Worker</td><td align="left" valign="middle" rowspan="1" colspan="1">62(19.31)</td><td align="left" valign="middle" rowspan="1" colspan="1">34(27.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">69.93</td><td align="left" valign="middle" rowspan="1" colspan="1">0.94(0.62-1.43)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Staff and others</td><td align="left" valign="middle" rowspan="1" colspan="1">146(45.48)</td><td align="left" valign="middle" rowspan="1" colspan="1">30(24.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">75.87</td><td align="left" valign="middle" rowspan="1" colspan="1">0.74(0.48-1.15)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Residence</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Urban</td><td align="left" valign="middle" rowspan="1" colspan="1">154(47.98)</td><td align="left" valign="middle" rowspan="1" colspan="1">63(50.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">71.74</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.967</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Rural</td><td align="left" valign="middle" rowspan="1" colspan="1">167(52.02)</td><td align="left" valign="middle" rowspan="1" colspan="1">62(49.60)</td><td align="left" valign="middle" rowspan="1" colspan="1">68.49</td><td align="left" valign="middle" rowspan="1" colspan="1">0.99(0.70-1.41)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Education level</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Primary and below</td><td align="left" valign="middle" rowspan="1" colspan="1">44(13.71)</td><td align="left" valign="middle" rowspan="1" colspan="1">13(10.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">65.56</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.983</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Middle school</td><td align="left" valign="middle" rowspan="1" colspan="1">229(71.34)</td><td align="left" valign="middle" rowspan="1" colspan="1">96(76.80)</td><td align="left" valign="middle" rowspan="1" colspan="1">70.82</td><td align="left" valign="middle" rowspan="1" colspan="1">1.01(0.57-1.81)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;College and above</td><td align="left" valign="middle" rowspan="1" colspan="1">48(14.95)</td><td align="left" valign="middle" rowspan="1" colspan="1">16(12.80)</td><td align="left" valign="middle" rowspan="1" colspan="1">70.07</td><td align="left" valign="middle" rowspan="1" colspan="1">1.06(0.51-2.21)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Family history of cancer</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="middle" rowspan="1" colspan="1">272(84.74)</td><td align="left" valign="middle" rowspan="1" colspan="1">104(83.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">72.11</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.774</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" valign="middle" rowspan="1" colspan="1">49(15.26)</td><td align="left" valign="middle" rowspan="1" colspan="1">21(16.80)</td><td align="left" valign="middle" rowspan="1" colspan="1">68.21</td><td align="left" valign="middle" rowspan="1" colspan="1">1.03(0.60-1.79)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Stage</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;I</td><td align="left" valign="middle" rowspan="1" colspan="1">65(20.25)</td><td align="left" valign="middle" rowspan="1" colspan="1">10(8.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">88.89</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;II</td><td align="left" valign="middle" rowspan="1" colspan="1">109(33.95)</td><td align="left" valign="middle" rowspan="1" colspan="1">33(26.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">77.58</td><td align="left" valign="middle" rowspan="1" colspan="1">2.05(1.01-4.15)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;III</td><td align="left" valign="middle" rowspan="1" colspan="1">97(30.22)</td><td align="left" valign="middle" rowspan="1" colspan="1">38(30.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">58.98</td><td align="left" valign="middle" rowspan="1" colspan="1">4.36(2.15-8.83)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;IV</td><td align="left" valign="middle" rowspan="1" colspan="1">50(15.58)</td><td align="left" valign="middle" rowspan="1" colspan="1">44(35.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">58.84</td><td align="left" valign="middle" rowspan="1" colspan="1">4.57(2.30-9.11)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">T stage</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;T1</td><td align="left" valign="middle" rowspan="1" colspan="1">75(23.36)</td><td align="left" valign="middle" rowspan="1" colspan="1">19(15.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">89.77</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;T2</td><td align="left" valign="middle" rowspan="1" colspan="1">126(39.25)</td><td align="left" valign="middle" rowspan="1" colspan="1">49(39.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">70.10</td><td align="left" valign="middle" rowspan="1" colspan="1">1.81(1.07-3.08)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;T3</td><td align="left" valign="middle" rowspan="1" colspan="1">90(28.04)</td><td align="left" valign="middle" rowspan="1" colspan="1">33(26.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">67.48</td><td align="left" valign="middle" rowspan="1" colspan="1">2.39(1.35-4.23)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;T4</td><td align="left" valign="middle" rowspan="1" colspan="1">30(9.35)</td><td align="left" valign="middle" rowspan="1" colspan="1">24(19.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">50.83</td><td align="left" valign="middle" rowspan="1" colspan="1">3.00(1.64-5.46)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">N stage</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;N0</td><td align="left" valign="middle" rowspan="1" colspan="1">241(75.08)</td><td align="left" valign="middle" rowspan="1" colspan="1">70(56.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">78.57</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;N1</td><td align="left" valign="middle" rowspan="1" colspan="1">46(14.33)</td><td align="left" valign="middle" rowspan="1" colspan="1">26(20.80)</td><td align="left" valign="middle" rowspan="1" colspan="1">55.48</td><td align="left" valign="middle" rowspan="1" colspan="1">2.68(1.69-4.25)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;N2-3</td><td align="left" valign="middle" rowspan="1" colspan="1">34(10.59)</td><td align="left" valign="middle" rowspan="1" colspan="1">29(23.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">44.07</td><td align="left" valign="middle" rowspan="1" colspan="1">3.13(2.02-4.85)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">M stage</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;M0</td><td align="left" valign="middle" rowspan="1" colspan="1">318(99.07)</td><td align="left" valign="middle" rowspan="1" colspan="1">120(96.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">70.51</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.114</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;M1</td><td align="left" valign="middle" rowspan="1" colspan="1">3(0.93)</td><td align="left" valign="middle" rowspan="1" colspan="1">5(4.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">50.00</td><td align="left" valign="middle" rowspan="1" colspan="1">2.03(0.83-4.99)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Histologic grade</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Well</td><td align="left" valign="middle" rowspan="1" colspan="1">159(49.53)</td><td align="left" valign="middle" rowspan="1" colspan="1">42(33.60)</td><td align="left" valign="middle" rowspan="1" colspan="1">81.14</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Moderate</td><td align="left" valign="middle" rowspan="1" colspan="1">132(41.12)</td><td align="left" valign="middle" rowspan="1" colspan="1">55(44.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">65.43</td><td align="left" valign="middle" rowspan="1" colspan="1">1.60(1.07-2.39)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Poor</td><td align="left" valign="middle" rowspan="1" colspan="1">30(9.35)</td><td align="left" valign="middle" rowspan="1" colspan="1">28(22.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">48.63</td><td align="left" valign="middle" rowspan="1" colspan="1">3.19(1.98-5.15)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Treatment</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Surgical</td><td align="left" valign="middle" rowspan="1" colspan="1">129(40.19)</td><td align="left" valign="middle" rowspan="1" colspan="1">35(28.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">67.91</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.390</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Surgical+CT</td><td align="left" valign="middle" rowspan="1" colspan="1">74(23.05)</td><td align="left" valign="middle" rowspan="1" colspan="1">28(22.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">76.80</td><td align="left" valign="middle" rowspan="1" colspan="1">0.74(0.45-1.23)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Surgical+RT</td><td align="left" valign="middle" rowspan="1" colspan="1">37(11.53)</td><td align="left" valign="middle" rowspan="1" colspan="1">15(12.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">70.19</td><td align="left" valign="middle" rowspan="1" colspan="1">0.99(0.54-1.81)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Surgical+CRT</td><td align="left" valign="middle" rowspan="1" colspan="1">81(25.23)</td><td align="left" valign="middle" rowspan="1" colspan="1">47(37.60)</td><td align="left" valign="middle" rowspan="1" colspan="1">65.90</td><td align="left" valign="middle" rowspan="1" colspan="1">1.12(0.72-1.74)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Smoking status</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="middle" rowspan="1" colspan="1">221(68.85)</td><td align="left" valign="middle" rowspan="1" colspan="1">75(60.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">70.78</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" valign="middle" rowspan="1" colspan="1">100(31.15)</td><td align="left" valign="middle" rowspan="1" colspan="1">50(40.00)</td><td align="left" valign="middle" rowspan="1" colspan="1">68.92</td><td align="left" valign="middle" rowspan="1" colspan="1">1.57(1.09-2.24)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Drinking status</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="middle" rowspan="1" colspan="1">254(79.13)</td><td align="left" valign="middle" rowspan="1" colspan="1">97(77.60)</td><td align="left" valign="middle" rowspan="1" colspan="1">71.27</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.574</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" valign="middle" rowspan="1" colspan="1">67(20.87)</td><td align="left" valign="middle" rowspan="1" colspan="1">28(22.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">69.04</td><td align="left" valign="middle" rowspan="1" colspan="1">1.13(0.74-1.72)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Oral hygiene</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Well</td><td align="left" valign="middle" rowspan="1" colspan="1">81(25.23)</td><td align="left" valign="middle" rowspan="1" colspan="1">24(19.20)</td><td align="left" valign="middle" rowspan="1" colspan="1">88.34</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Poor</td><td align="left" valign="middle" rowspan="1" colspan="1">240(74.77)</td><td align="left" valign="middle" rowspan="1" colspan="1">101(80.80)</td><td align="left" valign="middle" rowspan="1" colspan="1">64.59</td><td align="left" valign="middle" rowspan="1" colspan="1">1.92(1.22-3.02)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ill-fitting denture</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="middle" rowspan="1" colspan="1">189(58.88)</td><td align="left" valign="middle" rowspan="1" colspan="1">78(62.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">74.22</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" valign="middle" rowspan="1" colspan="1">132(41.12)</td><td align="left" valign="middle" rowspan="1" colspan="1">47(37.60)</td><td align="left" valign="middle" rowspan="1" colspan="1">65.26</td><td align="left" valign="middle" rowspan="1" colspan="1">1.67(1.15-2.42)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Comorbidity <sup>a</sup></td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="middle" rowspan="1" colspan="1">161(50.16)</td><td align="left" valign="middle" rowspan="1" colspan="1">57(45.60)</td><td align="left" valign="middle" rowspan="1" colspan="1">75.54</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00</td><td align="left" valign="middle" rowspan="1" colspan="1">0.124</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" valign="middle" rowspan="1" colspan="1">160(49.84)</td><td align="left" valign="middle" rowspan="1" colspan="1">68(54.40)</td><td align="left" valign="middle" rowspan="1" colspan="1">64.97</td><td align="left" valign="middle" rowspan="1" colspan="1">1.32(0.93-1.88)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>Abbreviations: CT, chemotherapy; RT, radiotherapy; CRT, chemoradiotherapy.</p><p><sup>a</sup> Comorbidity, the simultaneous existence of other medical conditions.</p></table-wrap-foot></table-wrap><p>Next, we performed a multivariate Cox regression analysis to develop different models by incorporating potentially significant or important factors obtained from Table <xref ref-type="table" rid="T2">2</xref>. As shown in Table <xref ref-type="table" rid="T3">3</xref>, the model-4 (including tumor stage, histologic grade, cigarette smoking, ill-fitting denture, oral hygiene) showed the highest Harrell's c-statistic (0.743), which had significant differences with model-1 (<italic>P</italic> &#x0003c; 0.001), model-2 (<italic>P</italic> = 0.036) and model-3 (<italic>P</italic> = 0.026), respectively. Moreover, the model-4 had the highest discriminatory ability for 5-year OS, with the lowest Akaike information criterion (AIC) value (1250.115). The above-mentioned data indicated that model-4 was a superior prognostic model for OSCC compared to other models.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Multivariate analysis of potential prognosis factors in four models in discovery group</title></caption><table frame="box" rules="all"><thead><tr><th rowspan="2" align="center" valign="middle" colspan="1">Variables</th><th colspan="2" align="center" valign="middle" rowspan="1">Model-1<sup>a</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">Model-2 <sup>b</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">Model-3 <sup>c</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">Model-4 <sup>d</sup></th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="middle" rowspan="1" colspan="1">HR(95 % CI)</th><th align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="middle" rowspan="1" colspan="1">HR(95 % CI)</th><th align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="middle" rowspan="1" colspan="1">HR(95 % CI)</th><th align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="middle" rowspan="1" colspan="1">HR(95 % CI)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Stage</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;I</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;II</td><td align="center" valign="middle" rowspan="1" colspan="1">0.58</td><td align="center" valign="middle" rowspan="1" colspan="1">1.79(0.87-3.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.82</td><td align="center" valign="middle" rowspan="1" colspan="1">2.26(1.10-4.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.61</td><td align="center" valign="middle" rowspan="1" colspan="1">1.84(0.90-3.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.73</td><td align="center" valign="middle" rowspan="1" colspan="1">2.08(1.01-4.29)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;III</td><td align="center" valign="middle" rowspan="1" colspan="1">1.35</td><td align="center" valign="middle" rowspan="1" colspan="1">3.86(1.89-7.90)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.32</td><td align="center" valign="middle" rowspan="1" colspan="1">3.73(1.82-7.64)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.47</td><td align="center" valign="middle" rowspan="1" colspan="1">4.35(2.11-8.95)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.25</td><td align="center" valign="middle" rowspan="1" colspan="1">3.50(1.67-7.31)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;IV</td><td align="center" valign="middle" rowspan="1" colspan="1">1.44</td><td align="center" valign="middle" rowspan="1" colspan="1">4.24(2.11-8.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.56</td><td align="center" valign="middle" rowspan="1" colspan="1">4.75(2.36-9.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.48</td><td align="center" valign="middle" rowspan="1" colspan="1">4.38(2.15-8.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.52</td><td align="center" valign="middle" rowspan="1" colspan="1">4.58(2.26-9.31)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Histologic grade</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Well</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Moderate</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43</td><td align="center" valign="middle" rowspan="1" colspan="1">1.53(1.01-2.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.45</td><td align="center" valign="middle" rowspan="1" colspan="1">1.57(1.04-2.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43</td><td align="center" valign="middle" rowspan="1" colspan="1">1.53(1.01-2.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.46</td><td align="center" valign="middle" rowspan="1" colspan="1">1.59(1.05-2.40)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Poor</td><td align="center" valign="middle" rowspan="1" colspan="1">1.20</td><td align="center" valign="middle" rowspan="1" colspan="1">3.33(2.04-5.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.22</td><td align="center" valign="middle" rowspan="1" colspan="1">3.39(2.07-5.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.05</td><td align="center" valign="middle" rowspan="1" colspan="1">2.86(1.74-4.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.28</td><td align="center" valign="middle" rowspan="1" colspan="1">3.61(2.17-6.03)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Smoking status</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">0.53</td><td align="center" valign="middle" rowspan="1" colspan="1">1.69(1.16-2.46)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.58</td><td align="center" valign="middle" rowspan="1" colspan="1">1.78(1.13-2.79)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ill-fitting denture</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.59</td><td align="center" valign="middle" rowspan="1" colspan="1">1.80(1.18-2.74)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.56</td><td align="center" valign="middle" rowspan="1" colspan="1">1.75(1.12-2.74)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Oral hygiene</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Well</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Poor</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.57</td><td align="center" valign="middle" rowspan="1" colspan="1">1.76(1.09-2.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.59</td><td align="center" valign="middle" rowspan="1" colspan="1">1.81(1.12-2.92)</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">Harrell's c-statistic (95 % CI)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.709(0.659-0.758)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.714(0.666-0.762)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.713(0.666-0.759)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.743(0.697-0.788)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AIC</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1264.644</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1264.201</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1265.276</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1250.115</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> Model-1 include age, sex, BMI, comorbidity, treatment, tumor stage, histologic grade and cigarette smoking; <sup>b</sup> Model-2 include age, sex, BMI, comorbidity, treatment, tumor stage, histologic grade and ill-fitting denture; <sup>c</sup> Model-3 include age, sex, BMI, comorbidity, treatment, tumor stage, histologic grade and oral hygiene; <sup>d</sup> Model-4 include age, sex, BMI, comorbidity, treatment, tumor stage, histologic grade, cigarette smoking, ill-fitting denture and oral hygiene.</p></table-wrap-foot></table-wrap><p>To further evaluate the prognostic value of model-4, we developed a composite PI according to five significant factors in model-4 (PI = 0.73&#x000d7;stage II +1.25&#x000d7;stage III +1.52&#x000d7;stage IV +0.46&#x000d7;moderate differentiation +1.28&#x000d7;poor differentiation +0.58&#x000d7;cigarette smoking +0.56&#x000d7;ill-fitting denture+0.59&#x000d7;oral hygiene). The median of PI was 2.30 ranging from 0 to 4.53, and the higher the PI, the poorer the survival. Then, the X-tile program determined 1.88 and 2.80 as the optimal cutoff values with the minimum P value (&#x003c7;<sup>2</sup> = 85.14, <italic>P</italic> &#x0003c; 0.001), which divided the cohort into low, middle and high risk subsets (Figure <xref ref-type="fig" rid="F1">1a-1b</xref>). Moreover, patients in high-risk group had the significantly worst OS than low-risk group (<italic>P</italic> &#x0003c; 0.001, Figure <xref ref-type="fig" rid="F1">1c</xref>; Table <xref ref-type="table" rid="T4">4</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>X-tile analysis on the optimal cutoff points of prognostic index for the discovery group</title><p>The optimal cut-point marked by the black point in the (<bold>a</bold>) is displayed on a histogram of the cohort (<bold>b</bold>), and a Kaplan-Meier plot (<bold>c</bold>).</p></caption><graphic xlink:href="oncotarget-08-55525-g001"/></fig><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>Association between PI value and the prognosis of patients with OSCC</title></caption><table frame="box" rules="all"><thead><tr><th rowspan="2" align="center" valign="middle" colspan="1">Variable</th><th colspan="2" align="center" valign="middle" rowspan="1">Discovery group</th><th colspan="2" align="center" valign="middle" rowspan="1">Validation group</th><th colspan="2" align="center" valign="middle" rowspan="1">All patients</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1"><italic>N</italic></th><th align="center" valign="middle" rowspan="1" colspan="1">HR(95%CI)<sup>a</sup></th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>N</italic></th><th align="center" valign="middle" rowspan="1" colspan="1">HR(95%CI)<sup>a</sup></th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>N</italic></th><th align="center" valign="middle" rowspan="1" colspan="1">HR(95%CI)<sup>a</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">PI</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Median(quartile)</td><td align="center" valign="middle" rowspan="1" colspan="1">446</td><td align="center" valign="middle" rowspan="1" colspan="1">2.30(1.61,2.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">446</td><td align="center" valign="middle" rowspan="1" colspan="1">2.33(1.63,3.10)</td><td align="center" valign="middle" rowspan="1" colspan="1">892</td><td align="center" valign="middle" rowspan="1" colspan="1">2.30(1.62,3.05)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">subgroup</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0-1.88 (low risk)</td><td align="center" valign="middle" rowspan="1" colspan="1">184</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">180</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">362</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1.89-2.80 (moderate risk)</td><td align="center" valign="middle" rowspan="1" colspan="1">136</td><td align="center" valign="middle" rowspan="1" colspan="1">1.90(1.14,3.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">128</td><td align="center" valign="middle" rowspan="1" colspan="1">2.48(1.52,4.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">266</td><td align="center" valign="middle" rowspan="1" colspan="1">2.06(1.46,2.88)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02265;2.81 (high risk)</td><td align="center" valign="middle" rowspan="1" colspan="1">126</td><td align="center" valign="middle" rowspan="1" colspan="1">7.47(4.57,12.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">138</td><td align="center" valign="middle" rowspan="1" colspan="1">5.30(3.28,8.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">264</td><td align="center" valign="middle" rowspan="1" colspan="1">6.21(4.43,8.70)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">P for trend</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.005</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AUROC</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.639(0.581,0.697)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.677(0.623,0.731)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.661(0.621,0.701)</td></tr></tbody></table></table-wrap><p>Furthermore, we re-examined the four model to validate the above results in an independent set. The model-4 still had the highest Harrell's c-statistic (0.738, 95%CI: 0.695-0.781; data not shown). Moreover, no significant difference of Harrell's c-statistic was observed between discovery group and validation group (<italic>P</italic> &#x0003e; 0.05). The overall survival rates were significantly different in the different PI groups, with <italic>P</italic> &#x0003c; 0.001 by log-rank test (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Kaplan-Meier curves for overall survival according to prognostic index in validation group</title></caption><graphic xlink:href="oncotarget-08-55525-g002"/></fig><p>We then estimated the clinical prediction value of PI in all OSCC patients. As shown in Table <xref ref-type="table" rid="T4">4</xref>, patients in high risk group were at the greatest risk of death compared with those in low risk group (HR: 6.02; 95%CI: 4.33-8.38). There was also a significant linear trend in the risk (<italic>P</italic>trend &#x0003c; 0.001). The 5-year OS rates for three risk subsets were 84.6%, 65.2% and 40.7%, respectively. Kaplan-Meier curve analysis also showed the similar results (Figure <xref ref-type="fig" rid="F3">3</xref>). For death prediction, the area under the receiver operating characteristic curve (AUROC) of PI was 0.661(95%CI: 0.621-0.701).</p><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Kaplan-Meier curves for overall survival according to prognostic index in all patients</title></caption><graphic xlink:href="oncotarget-08-55525-g003"/></fig></sec><sec id="s3"><title>DISCUSSION</title><p>In this large cohort prospective study, we developed and validated a novel prognostic index based on a superior prognostic model for OSCC. The model consisted of five significant factors: tumour stage, histologic grade, cigarette smoking, ill-fitting denture and oral hygiene. Moreover, there was a significant tendency of the worse OS with the higher PI value.</p><p>Among the significant prognostic factors in the present study, high clinical stage and poor tumor differentiation showed strong associations with risks of mortality among OSCC patients, which are traditional prognostic predictors and have been well-documented in many previous studies [<xref rid="R16" ref-type="bibr">16</xref>]. Cigarette smoking was found to be an independent predictor of survival in OSCC, which is consistent with other studies [<xref rid="R11" ref-type="bibr">11</xref>]. The carcinogens contained in tobacco smoke may affect the prognosis of OSCC by changing the oral microenvironment and inducing recurrent inflammatory responses [<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R18" ref-type="bibr">18</xref>]. Additionally, ill-fitting dentures could give rise to chronic mucosal irritation, and subsequently cause trauma and recurrent oral inflammation, which results in release of inflammatory mediators and growth factors that may be associated with a high rate of recurrence and a poor response to radiotherapy [<xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R20" ref-type="bibr">20</xref>]. The possible mechanism of poor oral hygiene on the worse outcome of OSCC may be that poor oral hygiene may induce the imbalance of oral flora and lead to postoperative inflammation easily, which may activate the specific chemokine that can regulate cell proliferation, survival and metastasis [<xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R21" ref-type="bibr">21</xref>].</p><p>Although several previous studies have created prognostic prediction models with different discriminatory ability for the prognosis of oral cancer [<xref rid="R13" ref-type="bibr">13</xref>&#x02013;<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R22" ref-type="bibr">22</xref>], the limitations of small sample size and short-term follow-up could not be avoided. Moreover, some of the parameters incorporated are not routine clinical measurements, which may limit the use of these models in clinical practice. In this study, we incorporated five conventional prognostic parameters to develop an easy applied prognostic prediction model, which is a credible tool to evaluate outcome as these variables are inexpensive and can be simple to calculate by physicians. The PI value with high discriminatory ability would better assess clinical prognosis and facilitate the development of individual treatment.</p><p>Nevertheless, there are several limitations in our study. First, we only included clinical features and lifestyle factors in the model, and did not consider serum markers and other novel biomarkers, which may limit the discriminatory capacity of PI within a certain range. However, taking more factors into account would increase the additional measurement cost, and make the model cannot gain widespread acceptance. Hopefully, other routine clinical measurements will also be considered to improve our model in future studies. Second, the variables were measured only at the start of the study but not at follow-up. It therefore needs further studies to get a further validation.</p><p>In conclusion, we developed and validated a prognostic index determined by a superior prognostic model for predicting the clinical outcomes of OSCC patients in Southeast China. The PI may be an economical, widely available and useful tool to plan therapeutic strategies and guide the schedule of individualized treatment. Future randomized trials with larger cohort are required to confirm our results.</p></sec><sec sec-type="methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4_1"><title>Study design and population</title><p>All study subjects were consecutively recruited between December 2003 and December 2015 at The First Affiliated Hospital of Fujian Medical University (Fujian, China). As described previously [<xref rid="R23" ref-type="bibr">23</xref>], subjects were included if they met the following conditions: (1) all patients were primary OSCC patients with histologically diagnosed; (2) all patients had underwent surgical resection; (3) all patients are all Chinese Han population who aged 20-80 years and reside in Fujian Province. Those who had other synchronous malignancies, or were diagnosed with recurrent oral cancer or metastasized cancer, were excluded from this study. The final analysis dataset consisted of 892 OSCC patients (26 lip, 447 tongue, 122 gingiva, 63 palate, 119 buccal, 66 floor of mouth, and 49 unspecified or overlapping). Informed consents were obtained from all patients. Our study was approved by the Institutional Review Board (IRB) of Fujian Medical University (Fuzhou, China) and conducted in line with the ethical standards described in the Declaration of Helsinki.</p></sec><sec id="s4_2"><title>Data collection</title><p>Information on demographics and lifestyle habits were obtained by trained interviewers through face-to-face interview with a structured questionnaire. Clinical characteristics (clinical stage, treatment types, tumor differentiation, histological types, comorbidity, etc.) were collected from medical records. Smokers were defined as those who had smoked at least 100 cigarettes during their lifetime. Oral hygiene status at diagnosis was evaluated by physicians through oral inspection. Ill-fitting denture refers to the denture with sharp or rough surfaces, or having overextended flanges, or lacking of stability and retention.</p></sec><sec id="s4_3"><title>Prospective follow-up</title><p>Follow-up data were obtained by telephone interview and medical records of readmission. Telephone interview was conducted every six months until the patient died or the final follow-up dated June 31, 2016. 892 OSCC patients were followed up for 3,124 person years. The median follow-up time was 70.7 months for all patients. During the follow-up period, a total of 271(30.38%) patients died (262 deaths from OSCC), 113(12.67%) were lost to follow up and 508(56.95%) were still alive. Those who were still alive or who died from other causes or who were lost to follow up were considered to be censored data. The primary endpoint was OS, which was calculated from the date of diagnosis to the date of death from any cause or the last follow up.</p></sec><sec id="s4_4"><title>Statistical analysis</title><p>Two-stage analyses were performed through randomly divided 892 patients into a discovery set (<italic>n</italic> = 446) and a validation set (<italic>n</italic> = 446). Univariate Cox regression model was utilized to estimate the associations between variables and OS. Four different multivariate Cox regression models were used to assess independent factors in OSCC prognosis. The superior prognostic model was evaluated and validated using Harrell's c-statistic and AIC. Then, a PI for OSCC was developed based on &#x003b2; value of each significant variable obtained from the superior model. The optimal cutoff points PI were identified using the X-tile program [<xref rid="R24" ref-type="bibr">24</xref>]. Trend test for PI was performed by entering PI subgroup as continuous variable in the regression model, and P value was obtained from Wald chi-square test. AUROC was calculated to evaluate the clinical prediction value and discriminatory capacity of PI. Survival curves were generated by the Kaplan-Meier method, and compared by the log-rank test. Statistical significance was defined when <italic>P</italic> &#x0003c; 0.05. All statistical analyses were conducted with R software (version 3.1.1).</p></sec></sec></body><back><ack><p>This study was funded by the Joint Funds for the Innovation of Science and Technology of Fujian province (No.2016Y9033), Natural Science Foundation of Fujian Province (No.2015J01304), and Nursery Research Fund of Fujian Medical University (No.2010MP019).</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST</bold></p><p>The authors declare no conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>SK</given-names></name><name><surname>Zheng</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>Oral cancer incidence and mortality in China, 2011</article-title><source>Chin J Cancer Res</source><year>2015</year><volume>27</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">25717225</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Dijk</surname><given-names>BA</given-names></name><name><surname>Brands</surname><given-names>MT</given-names></name><name><surname>Geurts</surname><given-names>SM</given-names></name><name><surname>Merkx</surname><given-names>MA</given-names></name><name><surname>Roodenburg</surname><given-names>JL</given-names></name></person-group><article-title>Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands</article-title><source>Int J Cancer</source><year>2016</year><volume>139</volume><fpage>574</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">27038013</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freier</surname><given-names>K</given-names></name><name><surname>Engel</surname><given-names>M</given-names></name><name><surname>Lindel</surname><given-names>K</given-names></name><name><surname>Flechtenmacher</surname><given-names>C</given-names></name><name><surname>Muhling</surname><given-names>J</given-names></name><name><surname>Hassfeld</surname><given-names>S</given-names></name><name><surname>Hofele</surname><given-names>C</given-names></name></person-group><article-title>Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients</article-title><source>Oral Oncol</source><year>2008</year><volume>44</volume><fpage>116</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">17350327</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillon</surname><given-names>JK</given-names></name><name><surname>Brown</surname><given-names>CB</given-names></name><name><surname>McDonald</surname><given-names>TM</given-names></name><name><surname>Ludwig</surname><given-names>DC</given-names></name><name><surname>Clark</surname><given-names>PJ</given-names></name><name><surname>Leroux</surname><given-names>BG</given-names></name><name><surname>Futran</surname><given-names>ND</given-names></name></person-group><article-title>How does the close surgical margin impact recurrence and survival when treating oral squamous cell carcinoma?</article-title><source>J Oral Maxillofac Surg</source><year>2015</year><volume>73</volume><fpage>1182</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">25795179</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>PC</given-names></name><name><surname>Miguel</surname><given-names>MC</given-names></name><name><surname>Bagordakis</surname><given-names>E</given-names></name><name><surname>Fonseca</surname><given-names>FP</given-names></name><name><surname>de Aquino</surname><given-names>SN</given-names></name><name><surname>Santos-Silva</surname><given-names>AR</given-names></name><name><surname>Lopes</surname><given-names>MA</given-names></name><name><surname>Graner</surname><given-names>E</given-names></name><name><surname>Salo</surname><given-names>T</given-names></name><name><surname>Kowalski</surname><given-names>LP</given-names></name><name><surname>Coletta</surname><given-names>RD</given-names></name></person-group><article-title>Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases</article-title><source>Int J Oral Maxillofac Surg</source><year>2014</year><volume>43</volume><fpage>795</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">24583139</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>B</given-names></name></person-group><article-title>Prospective study on factors affecting the prognosis of oral cancer in a Chinese population</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>4352</fpage><lpage>4359</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.13842</pub-id><pub-id pub-id-type="pmid">28032596</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>LP</given-names></name><name><surname>Zhang</surname><given-names>CP</given-names></name><name><surname>Ren</surname><given-names>GX</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>William</surname><given-names>WN</given-names><suffix>Jr</suffix></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>HG</given-names></name><name><surname>Tu</surname><given-names>WY</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>YL</given-names></name><name><surname>Wang</surname><given-names>LZ</given-names></name><name><surname>Fan</surname><given-names>XD</given-names></name><name><surname>Wang</surname><given-names>ZH</given-names></name><etal/></person-group><article-title>Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma</article-title><source>J Clin Oncol</source><year>2013</year><volume>31</volume><fpage>744</fpage><lpage>751</lpage><pub-id pub-id-type="pmid">23129742</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>HY</given-names></name><name><surname>Huang</surname><given-names>XY</given-names></name><name><surname>Chien</surname><given-names>HT</given-names></name><name><surname>Chang</surname><given-names>JT</given-names></name><name><surname>Liao</surname><given-names>CT</given-names></name><name><surname>Huang</surname><given-names>JJ</given-names></name><name><surname>Wei</surname><given-names>FC</given-names></name><name><surname>Wang</surname><given-names>HM</given-names></name><name><surname>Chen</surname><given-names>IH</given-names></name><name><surname>Kang</surname><given-names>CJ</given-names></name><name><surname>Huang</surname><given-names>SF</given-names></name></person-group><article-title>Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma</article-title><source>Laryngoscope</source><year>2013</year><volume>123</volume><fpage>2690</fpage><lpage>2699</lpage><pub-id pub-id-type="pmid">23619955</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>B</given-names></name></person-group><article-title>Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of oral squamous cell carcinoma: a large-sample prospective study</article-title><source>J Oral Maxillofac Surg</source><year>2017</year><volume>75</volume><fpage>1275</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1016/j.joms.2016.11.022</pub-id><pub-id pub-id-type="pmid">28011326</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duray</surname><given-names>A</given-names></name><name><surname>Descamps</surname><given-names>G</given-names></name><name><surname>Decaestecker</surname><given-names>C</given-names></name><name><surname>Remmelink</surname><given-names>M</given-names></name><name><surname>Sirtaine</surname><given-names>N</given-names></name><name><surname>Lechien</surname><given-names>J</given-names></name><name><surname>Ernoux-Neufcoeur</surname><given-names>P</given-names></name><name><surname>Bletard</surname><given-names>N</given-names></name><name><surname>Somja</surname><given-names>J</given-names></name><name><surname>Depuydt</surname><given-names>CE</given-names></name><name><surname>Delvenne</surname><given-names>P</given-names></name><name><surname>Saussez</surname><given-names>S</given-names></name></person-group><article-title>Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma</article-title><source>Laryngoscope</source><year>2012</year><volume>122</volume><fpage>1558</fpage><lpage>1565</lpage><pub-id pub-id-type="pmid">22532307</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakita</surname><given-names>D</given-names></name><name><surname>Hosono</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Oze</surname><given-names>I</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Hanai</surname><given-names>N</given-names></name><name><surname>Hasegawa</surname><given-names>Y</given-names></name><name><surname>Tajima</surname><given-names>K</given-names></name><name><surname>Murakami</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name></person-group><article-title>Impact of smoking status on clinical outcome in oral cavity cancer patients</article-title><source>Oral Oncol</source><year>2012</year><volume>48</volume><fpage>186</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">21996543</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morais</surname><given-names>MO</given-names></name><name><surname>Elias</surname><given-names>MR</given-names></name><name><surname>Leles</surname><given-names>CR</given-names></name><name><surname>JC</surname><given-names>Dourado Pinezi</given-names></name><name><surname>Mendonca</surname><given-names>EF</given-names></name></person-group><article-title>The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients</article-title><source>Support Care Cancer</source><year>2016</year><volume>24</volume><fpage>1663</fpage><lpage>1670</lpage><pub-id pub-id-type="pmid">26408325</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tertipis</surname><given-names>N</given-names></name><name><surname>Hammar</surname><given-names>U</given-names></name><name><surname>Nasman</surname><given-names>A</given-names></name><name><surname>Vlastos</surname><given-names>A</given-names></name><name><surname>Nordfors</surname><given-names>C</given-names></name><name><surname>Grun</surname><given-names>N</given-names></name><name><surname>Ahrlund-Richter</surname><given-names>A</given-names></name><name><surname>Sivars</surname><given-names>L</given-names></name><name><surname>Haeggblom</surname><given-names>L</given-names></name><name><surname>Marklund</surname><given-names>L</given-names></name><name><surname>Hammarstedt-Nordenvall</surname><given-names>L</given-names></name><name><surname>Chaturvedi</surname><given-names>AK</given-names></name><name><surname>Munck-Wikland</surname><given-names>E</given-names></name><etal/></person-group><article-title>A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer</article-title><source>Eur J Cancer</source><year>2015</year><volume>51</volume><fpage>1580</fpage><lpage>1587</lpage><pub-id pub-id-type="pmid">26025766</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rietbergen</surname><given-names>MM</given-names></name><name><surname>Witte</surname><given-names>BI</given-names></name><name><surname>Velazquez</surname><given-names>ER</given-names></name><name><surname>Snijders</surname><given-names>PJ</given-names></name><name><surname>Bloemena</surname><given-names>E</given-names></name><name><surname>Speel</surname><given-names>EJ</given-names></name><name><surname>Brakenhoff</surname><given-names>RH</given-names></name><name><surname>Kremer</surname><given-names>B</given-names></name><name><surname>Lambin</surname><given-names>P</given-names></name><name><surname>Leemans</surname><given-names>CR</given-names></name></person-group><article-title>Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe</article-title><source>Br J Cancer</source><year>2015</year><volume>112</volume><fpage>1733</fpage><lpage>1736</lpage><pub-id pub-id-type="pmid">25950384</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almangush</surname><given-names>A</given-names></name><name><surname>Coletta</surname><given-names>RD</given-names></name><name><surname>Bello</surname><given-names>IO</given-names></name><name><surname>Bitu</surname><given-names>C</given-names></name><name><surname>Keski-Santti</surname><given-names>H</given-names></name><name><surname>Makinen</surname><given-names>LK</given-names></name><name><surname>Kauppila</surname><given-names>JH</given-names></name><name><surname>Pukkila</surname><given-names>M</given-names></name><name><surname>Hagstrom</surname><given-names>J</given-names></name><name><surname>Laranne</surname><given-names>J</given-names></name><name><surname>Tommola</surname><given-names>S</given-names></name><name><surname>Soini</surname><given-names>Y</given-names></name><name><surname>Kosma</surname><given-names>VM</given-names></name><etal/></person-group><article-title>A simple novel prognostic model for early stage oral tongue cancer</article-title><source>Int J Oral Maxillofac Surg</source><year>2015</year><volume>44</volume><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">25457829</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreppel</surname><given-names>M</given-names></name><name><surname>Nazarli</surname><given-names>P</given-names></name><name><surname>Grandoch</surname><given-names>A</given-names></name><name><surname>Safi</surname><given-names>AF</given-names></name><name><surname>Zirk</surname><given-names>M</given-names></name><name><surname>Nickenig</surname><given-names>HJ</given-names></name><name><surname>Scheer</surname><given-names>M</given-names></name><name><surname>Rothamel</surname><given-names>D</given-names></name><name><surname>Hellmich</surname><given-names>M</given-names></name><name><surname>Zoller</surname><given-names>JE</given-names></name></person-group><article-title>Clinical and histopathological staging in oral squamous cell carcinoma - Comparison of the prognostic significance</article-title><source>Oral Oncol</source><year>2016</year><volume>60</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">27531875</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>PS</given-names></name><name><surname>Matthews</surname><given-names>CR</given-names></name><name><surname>Joshi</surname><given-names>V</given-names></name><name><surname>de Jager</surname><given-names>M</given-names></name><name><surname>Aspiras</surname><given-names>M</given-names></name></person-group><article-title>Tobacco smoking affects bacterial acquisition and colonization in oral biofilms</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>4730</fpage><lpage>4738</lpage><pub-id pub-id-type="pmid">21859855</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlage</surname><given-names>WK</given-names></name><name><surname>Iskandar</surname><given-names>AR</given-names></name><name><surname>Kostadinova</surname><given-names>R</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Sewer</surname><given-names>A</given-names></name><name><surname>Majeed</surname><given-names>S</given-names></name><name><surname>Kuehn</surname><given-names>D</given-names></name><name><surname>Frentzel</surname><given-names>S</given-names></name><name><surname>Talikka</surname><given-names>M</given-names></name><name><surname>Geertz</surname><given-names>M</given-names></name><name><surname>Mathis</surname><given-names>C</given-names></name><name><surname>Ivanov</surname><given-names>N</given-names></name><name><surname>Hoeng</surname><given-names>J</given-names></name><etal/></person-group><article-title><italic>In vitro</italic> systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures</article-title><source>Toxicol Mech Methods</source><year>2014</year><volume>24</volume><fpage>470</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">25046638</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>BC</given-names></name><name><surname>Yan</surname><given-names>LJ</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>LS</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name></person-group><article-title>Influence of oral hygiene and its interaction with standard of education on the risk of oral cancer in women who neither smoked nor drank alcohol: a hospital-based, case-control study</article-title><source>Br J Oral Maxillofac Surg</source><year>2017</year><volume>55</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.bjoms.2016.11.316</pub-id><pub-id pub-id-type="pmid">27908460</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feller</surname><given-names>L</given-names></name><name><surname>Altini</surname><given-names>M</given-names></name><name><surname>Lemmer</surname><given-names>J</given-names></name></person-group><article-title>Inflammation in the context of oral cancer</article-title><source>Oral Oncol</source><year>2013</year><volume>49</volume><fpage>887</fpage><lpage>892</lpage><pub-id pub-id-type="pmid">23910564</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perera</surname><given-names>M</given-names></name><name><surname>Al-Hebshi</surname><given-names>NN</given-names></name><name><surname>Speicher</surname><given-names>DJ</given-names></name><name><surname>Perera</surname><given-names>I</given-names></name><name><surname>Johnson</surname><given-names>NW</given-names></name></person-group><article-title>Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria</article-title><source>J Oral Microbiol</source><year>2016</year><volume>8</volume><fpage>32762</fpage><pub-id pub-id-type="pmid">27677454</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>SM</given-names></name><name><surname>Busse</surname><given-names>PM</given-names></name><name><surname>Clark</surname><given-names>JR</given-names></name><name><surname>Wirth</surname><given-names>LJ</given-names></name><name><surname>Ancukiewicz</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>AW</given-names></name></person-group><article-title>Long-term survival after distant metastasis in patients with oropharyngeal cancer</article-title><source>Oral Oncol</source><year>2014</year><volume>50</volume><fpage>208</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">24387975</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>B</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name></person-group><article-title>FADS1 rs174549 Polymorphism May Predict a Favorable Response to Chemoradiotherapy in Oral Cancer Patients</article-title><source>J Oral Maxillofac Surg</source><year>2017</year><volume>75</volume><fpage>214</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.joms.2016.07.005</pub-id><pub-id pub-id-type="pmid">27542551</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camp</surname><given-names>RL</given-names></name><name><surname>Dolled-Filhart</surname><given-names>M</given-names></name><name><surname>Rimm</surname><given-names>DL</given-names></name></person-group><article-title>X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><fpage>7252</fpage><lpage>7259</lpage><pub-id pub-id-type="pmid">15534099</pub-id></element-citation></ref></ref-list></back></article>